Blastic plasmacytoid dendritic cell neoplasm: Extensive disease, Langer lines, and blood burden in a retrospective study of 66 cases

Affiliations

• ¹ Department of Dermatology, Brigham and Women's Hospital, and the Center for Cutaneous Oncology, Dana-Farber/Brigham Cancer Center, Boston, MA.
• ² Department of Dermatology, University of Missouri Health Care, Columbia, MO.
• ³ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA; Rabin Medical Center and Faculty of Medicine, Tel Aviv University, Israel.
• ⁴ Department of Dermatology, Stanford University Medical Center, Stanford, CA.
• ⁵ Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA; Harvard Medical School, Boston, MA.
• ⁶ Department of Dermatology, Brigham and Women's Hospital, and the Center for Cutaneous Oncology, Dana-Farber/Brigham Cancer Center, Boston, MA; Harvard Medical School, Boston, MA. Electronic address: nleboeuf@bwh.harvard.edu.